title: Aminoglycoside induced nephrotoxicity: molecular modeling studies of calreticulin-gentamicin complex.
abstract: Gentamicin is a member of aminoglycoside group of broad spectrum antibiotics. It impairs protein synthesis by binding to A site of the 30S subunit of bacterial ribosomes. One of the main side effects of this drug is nephrotoxicity. The drug is known to bind to calreticulin, a chaperone essential for the folding of glycosylated proteins. We provide a detailed structural insight of the calreticulin-gentamicin complex by molecular modeling and the binding of the drug in the presence of explicit solvent was analyzed by molecular dynamics simulation. The gentamicin molecule binds to the lectin site of the calreticulin and lies in the concave channel formed by the long beta sheets. It makes interactions with residues Tyr109, Asp125, Asp135, Asp317 and Trp319 which are crucial for the chaperone function of the calreticulin. The superimposing of the modeled complex with the only available crystal structure complex of calreticulin with a tetrasaccharide (Glc(1)Man(3)) shows interesting features. First, the rings of the gentamicin occupy the positions of glucose and the first two mannose sugars of the tetrasaccharide molecule. Second, the oxygen atoms of the glycosidic linkage of these two ligands have a positional deviation of 1.3 Ǻ. The predicted binding constant of 16.9 μM is in accordance with the previous kinetic study experiments. The details therefore, strongly implicate gentamicin as a competitive inhibitor of sugar binding with calreticulin.
authors.affiliation: Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Gururao
authors.initials: G
authors.lastname: Hariprasad
authors.forename: Manoj
authors.initials: M
authors.lastname: Kumar
authors.forename: Komal
authors.initials: K
authors.lastname: Rani
authors.forename: Punit
authors.initials: P
authors.lastname: Kaur
authors.forename: Alagiri
authors.initials: A
authors.lastname: Srinivasan
mesh_terms: D020816:Amino Acid Motifs; D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry*; D001665:Binding Sites; D001667:Binding, Competitive; D037282:Calreticulin / Q000737:chemistry*; D015195:Drug Design; D005839:Gentamicins / Q000737:chemistry*; D006801:Humans; D006860:Hydrogen Bonding; D056004:Molecular Dynamics Simulation; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D013499:Surface Properties; D013816:Thermodynamics; D014867:Water / Q000737:chemistry
chemical_list: D000900:Anti-Bacterial Agents; D037282:Calreticulin; D005839:Gentamicins; D014867:Water
references.citation: Toxicol Sci. 2007 Sep;99(1):346-53
references.pmid: 17567590
references.citation: Toxicol Sci. 2011 Feb;119(2):245-56
references.pmid: 20829429
references.citation: Biochemistry. 2004 Jan 13;43(1):97-106
references.pmid: 14705935
references.citation: J Cell Sci. 1994 Oct;107 ( Pt 10):2705-17
references.pmid: 7876339
references.citation: J Biol Chem. 2010 Dec 3;285(49):38612-20
references.pmid: 20880849
references.citation: FEBS Lett. 2010 Feb 19;584(4):645-51
references.pmid: 20026329
references.citation: Methods Mol Biol. 2010;648:3-23
references.pmid: 20700702
references.citation: Antioxid Redox Signal. 2007 Dec;9(12):2277-93
references.pmid: 17979528
references.citation: Clin Exp Nephrol. 2008 Oct;12(5):317-325
references.pmid: 18536867
references.citation: Cell Death Dis. 2010 Jul 01;1:e51
references.pmid: 21364656
references.citation: J Mol Graph Model. 2005 Apr;23(5):395-407
references.pmid: 15781182
references.citation: J Biol Chem. 1995 Mar 3;270(9):4697-704
references.pmid: 7876241
references.citation: Pharmacol Res. 2010 Sep;62(3):179-86
references.pmid: 20434560
references.citation: Apoptosis. 2008 Jan;13(1):11-32
references.pmid: 17968659
references.citation: Int J Antimicrob Agents. 2009 Mar;33(3):201-5
references.pmid: 18976888
references.citation: EMBO J. 1996 Apr 1;15(7):1495-506
references.pmid: 8612572
references.citation: J Biol Chem. 2004 Apr 23;279(17):17295-300
references.pmid: 14966137
references.citation: J Mol Graph Model. 2003 Jan;21(4):289-307
references.pmid: 12479928
references.citation: Yakugaku Zasshi. 2011 Mar;131(3):437-43
references.pmid: 21372541
references.citation: J Infect Dis. 1984 Feb;149(2):257-63
references.pmid: 6421944
references.citation: Biochem Biophys Res Commun. 2004 Oct 8;323(1):281-7
references.pmid: 15351734
references.citation: Cell Stress Chaperones. 2005 Autumn;10(3):242-51
references.pmid: 16184769
references.citation: PLoS One. 2007 Nov 14;2(11):e1176
references.pmid: 18000547
references.citation: Ren Fail. 2011;33(3):341-7
references.pmid: 21401361
references.citation: Mol Cell. 2001 Sep;8(3):633-44
references.pmid: 11583625
references.citation: Semin Respir Crit Care Med. 2007 Dec;28(6):596-603
references.pmid: 18095223
references.citation: J Biol Chem. 1996 May 10;271(19):11588-94
references.pmid: 8626722
references.citation: FEBS J. 2007 Feb;274(3):630-58
references.pmid: 17288551
references.citation: Prog Clin Biol Res. 1979;35:33-41
references.pmid: 395539
references.citation: J Biol Chem. 1968 Jun 25;243(12):3312-6
references.pmid: 5656371
references.citation: Genes Dev. 1999 May 15;13(10):1211-33
references.pmid: 10346810
references.citation: Biochem Biophys Res Commun. 2006 Dec 8;351(1):14-20
references.pmid: 17049488
references.citation: Ren Fail. 1999 May-Jul;21(3-4):433-42
references.pmid: 10416224
references.citation: Toxicol Appl Pharmacol. 2007 Aug 15;223(1):86-98
references.pmid: 17602717
references.citation: Eur J Pharmacol. 2011 May 11;658(2-3):213-8
references.pmid: 21371463
references.citation: Antimicrob Agents Chemother. 2011 Jun;55(6):2532-6
references.pmid: 21402854
references.citation: Antimicrob Agents Chemother. 2009 Jul;53(7):2887-91
references.pmid: 19364846
references.citation: J Biol Chem. 2003 Feb 21;278(8):6194-200
references.pmid: 12464625
references.citation: Nefrologia. 2000 Sep-Oct;20(5):408-14
references.pmid: 11100661